229 Studies Now Enrolling
Menu
Search
Medical Condition
- Show all (171)
- Blood Disorders (1)
- Cancer (100)
- COVID-19 (Coronavirus) (1)
- Diabetes (2)
- Ear, Nose and Throat (1)
- Endocrine & Metabolic Disease (2)
- Gastrointestinal and Digestive Diseases (2)
- Healthy Volunteers (7)
- (-) Heart Disease (2)
- Liver Disease (1)
- Neurological Disorders (3)
- Obesity (2)
- Obstetrics & Gynecology (6)
- Pediatrics (37)
- Psychiatric Disorders (1)
- Surgery (1)
- Transplant (2)
Displaying 1 - 4 of 4
Condition: Cancer / Brain Cancer
Investigator: James Hinkley Garvin Jr, MD
Status: Closed
The purpose of this study is to find the best dose of a drug called MTX110 and a contrast agent called gadolinium that can be given safely in children with newly diagnosed diffuse midline gliomas, which is a kind of brain tumor. All patients enrolled in the study will receive infusion of MTX110 and Gadolinium delivered with a pump directly into the tumor…
Condition: Cancer / Brain Cancer
Investigator: Mikhail Doubrovin, MD
Status: Closed
The purpose of the study is to evaluate the safety of Lutathera alone in patients with recurrent glioblastoma and the combination of Lutathera with radiotherapy with temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GB) and to establish the appropriate dose of this combination. Lutathera is a radioligand therapy, which is a targeted…
Condition: Heart Disease
Investigator: Nour Makarem, PhD
Status: Currently Recruiting
The Mailman School of Public Health at Columbia University is doing a research study to learn how to best improve sleep health in couples for supporting heart health. We are looking for couples aged 30-65 years with no history of cancer or heart disease. To see if individuals qualify for the study, couples who are interested…
Condition: Heart Disease
Investigator: Nour Makarem, PhD
Status: Currently Recruiting
The Mailman School of Public Health at Columbia University is doing a research study to learn how improving sleep habits affects heart health. We are looking for adults aged 30+ years with no history of cancer or heart disease. To see if individuals qualify for the study, those who are interested in participating will first do…